Purpose
To report the esophageal toxicity from single-fraction paraspinal stereotactic radiosurgery (SRS) and identify dosimetric and clinical risk factors for toxicity.
Methods and Materials
204 spinal metastases abutting the esophagus (182 patients) were treated with high-dose single-fraction SRS during 2003-2010. Toxicity was scored using NCI CTCAE 4.0. Dose-volume histograms (DVHs) were combined to generate a comprehensive atlas of complication incidence that identifies risk factors for toxicity. Correlation of dose-volume factors with esophageal toxicity were assessed using Fishers exact test and logistic regression. Clinical factors were correlated with toxicity.
Results
The median dose to the planning treatment volume was 24 Gy. Median follow-up was 12 months (range 3-81). There were 31 (15%) acute and 24 (12%) late esophageal toxicities. The rate of grade ≥3 acute or late toxicity was 6.8% (14 patients). Fisher’s exact test resulted in significant median splits for grade ≥3 toxicity at V12 = 3.78 cm3 (relative risk [RR] 3.7, p = 0.05), V15 = 1.87 cm3 (RR 13, p = 0.0013), V20 = 0.11 cm3 (RR = 6, p = 0.01), and V22 = 0.0 cm3 (RR 13, p = 0.0013). The median split for D2.5 cm3 (14.02 Gy) was also a significant predictor of toxicity (RR6; p=0.01). A highly significant logistic regression model was generated based on D2.5 cm3. 100% (n = 7) of grade ≥4 toxicities were associated with radiation recall reactions after adriamycin or gemcitabine chemotherapy or iatrogenic manipulation of the irradiated esophagus.
Conclusions
High dose, single fraction paraspinal SRS has a low rate of grade ≥ 3 esophageal toxicity. Severe esophageal toxicity is minimized with careful attention to esophageal doses during treatment planning. Iatrogenic manipulation of the irradiated esophagus and systemic agents classically associated with radiation recall reactions are associated with development of grade ≥4 toxicity.